{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:28:17Z","timestamp":1744874897335},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T00:00:00Z","timestamp":1410307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00115-014-4157-9","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T15:11:21Z","timestamp":1410189081000},"page":"1304-1308","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Akute Psychose als Nebenwirkung der Therapie mit Efavirenz bei metabolischer Anomalie"],"prefix":"10.1007","volume":"85","author":[{"given":"M.C.","family":"Hinsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.W.","family":"Husstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40263-013-0132-4","volume":"28","author":"Abers","year":"2014","unstructured":"Abers MS, Shandera WX, Kass JS (2014) Neurological and psychiatric 251 adverse effects of antiretroviral drugs. CNS Drugs 28(2):131\u2013145","journal-title":"CNS Drugs"},{"key":"4157_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2013.03.011","volume":"147","author":"Amad","year":"2013","unstructured":"Amad A, Guardia D, Salleron J et al (2013) Increased prevalence of psychotic disorders among third-generation migrants: results from the French Mental Health in General Population survey. Schizophr Res 147(1):193\u2013195","journal-title":"Schizophr Res"},{"key":"4157_CR3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Wojna VE et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799","journal-title":"Neurology"},{"key":"4157_CR4","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1097\/QAD.0b013e328340fe76","volume":"24","author":"Asselman","year":"2010","unstructured":"Asselman V, Thienemann F, Pepper DJ et al (2010) Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 24(18):2871\u20132876","journal-title":"AIDS"},{"key":"4157_CR5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/AAC.02329-12","volume":"57","author":"Avery","year":"2013","unstructured":"Avery LB, Sacktor N et al (2013) Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration. Antimicrob Agents Chemother 57(3):1409\u20131414","journal-title":"Antimicrob Agents Chemother"},{"key":"4157_CR6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00115-010-3124-3","volume":"82","author":"Baumschlager","year":"2011","unstructured":"Baumschlager D, Haas-Krammer A, Rothenh\u00e4usler HB (2011) Emotional status, cognitive performance and quality of life in HIV-infected patients. Results of an exploratory study. Nervenarzt 82(7):902\u2013909","journal-title":"Nervenarzt"},{"key":"4157_CR7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0031-1292832","volume":"39","author":"Bermejo","year":"2012","unstructured":"Bermejo I, Frank F, Maier I, H\u00f6lzel LP (2012) Health care utilisation of migrants with mental disorders compared with Germans. Psychiatr Prax 39(2):64\u201370","journal-title":"Psychiatr Prax"},{"key":"4157_CR8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jac\/dkq434","volume":"66","author":"Best","year":"2011","unstructured":"Best BM, Koopmans PP, Letendre SL et al (2011) Efavirenz concentrations in CSF exceed IC50 for wild275 type HIV. J Antimicrob Chemother 66:354\u2013357","journal-title":"J Antimicrob Chemother"},{"key":"4157_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00207454.2010.520541","volume":"120","author":"Cavalcante","year":"2010","unstructured":"Cavalcante GI, Capistrano VL et al (2010) Implications of efavirenz for neuropsychiatriy: a review. Int J Neurosci 120(12):739\u2013745","journal-title":"Int J Neurosci"},{"key":"4157_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2013.45.2.239","volume":"45","author":"Choi","year":"2013","unstructured":"Choi JY (2013) Mental health of HIV-infected patients: a severe, but overlooked problem. Infect Chemother 45(2):239\u2013240","journal-title":"Infect Chemother"},{"key":"4157_CR11","unstructured":"Cournos C, McKinnon K (2008) Epidemiology of psychiatric disorders associated with HIV\/AIDS. In: Cohen MA, Gorman JM (Hrsg) Comprehensive Textbook of AIDS Psychiatry. Oxford University press, New York S\u00a039\u201348"},{"key":"4157_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FPC.0b013e32835cb2e2","volume":"23","author":"Dobrinas","year":"2013","unstructured":"Dobrinas M, Crettol S, Oneda B et al (2013) Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study. Pharmacogenet Genomics 23(2):84\u201393","journal-title":"Pharmacogenet Genomics"},{"key":"4157_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/008124630803800304","volume":"38","author":"Freeman","year":"2008","unstructured":"Freeman M, Nkomo N, Kafaar Z, Kelly K (2008) Mental disorder in people living with HIV\/AIDS in South Africa. S Afr J Psych 38(3):489\u2013500","journal-title":"S Afr J Psych"},{"key":"4157_CR14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1086\/522175","volume":"45","author":"Gatanaga","year":"2007","unstructured":"Gatanaga H, Hayashida T, Tsuchiya K et al (2007) Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26. Clin Infect Dis 45:1230\u20131237","journal-title":"Clin Infect Dis"},{"key":"4157_CR15","first-page":"2391","volume":"18","author":"Haas","year":"2004","unstructured":"Haas DW, Ribaudo HJ, Kim RB et al (2004) Pharmacogenetics of efavirenz and central nervous system side effects: an adult AIDS clinical trials group study. AIDS 18:2391\u20132400","journal-title":"AIDS"},{"key":"4157_CR16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","volume":"27","author":"Jefferson","year":"2005","unstructured":"Jefferson JW, Pradko JF, Muir KT (2005) Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther 27(11):1685\u20131695","journal-title":"Clin Ther"},{"key":"4157_CR17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4088\/JCP.12m07814","volume":"73","author":"Jia","year":"2012","unstructured":"Jia CX, Mehlum L, Qin P (2012) AIDS\/HIV infection, comorbid psychiatric illness, and risk for subsequent suicide: a nationwide register linkage study. J Clin Psychiatry 73(10):1315\u20131321","journal-title":"J Clin Psychiatry"},{"key":"4157_CR18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2174\/157016212802429857","volume":"10","author":"Jin","year":"2012","unstructured":"Jin YH, Potthoff A, Xu J et al (2012) Evaluation of mental status HIV-infected patients: implications for treatment.Curr HIV Res 10(6):546\u2013551","journal-title":"Curr HIV Res"},{"key":"4157_CR19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L et al (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382(9896):951\u2013962","journal-title":"Lancet"},{"key":"4157_CR20","first-page":"115","volume":"Psychiatry","author":"Owe-Larsson","year":"2009","unstructured":"Owe-Larsson B, S\u00e4ll L, Salamon E, Allgulander C et al (2009) HIV infection and psychiatric illness. Afr J Psychiatry (Johannesbg) 12(2):115\u2013128","journal-title":"Afr J"},{"key":"4157_CR21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-1293.2006.00419.x","volume":"7","author":"Rihs","year":"2006","unstructured":"Rihs TA, Begley K et al (2006) Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 7(8):544\u2013548","journal-title":"HIV Med"},{"key":"4157_CR22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.clpt.6100072","volume":"81","author":"Rotger","year":"2007","unstructured":"Rotger M, Tegude H, Colombo S et al (2007) Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clin Pharmacol Ther 81:557\u2013566","journal-title":"Clin Pharmacol Ther"},{"key":"4157_CR23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/314945","volume":"180","author":"Tashima","year":"1999","unstructured":"Tashima KT, Caliendo AM, Ahmad M et al (1999) Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. J Infect Dis 180:862\u2013864","journal-title":"J Infect Dis"},{"key":"4157_CR24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dkn029","volume":"61","author":"Wyen","year":"2008","unstructured":"Wyen C, Hendra H et al (2008) Impact of CYP2B6 983T > C polymorphism on non333 nucleoside reverse transcriptase inhibitor plasma concentrations in HIV334 infected patients. J Antimicrob Chemother 61:914\u2013918","journal-title":"J Antimicrob Chemother"},{"key":"4157_CR25","first-page":"119","volume":"88","author":"Zalila","year":"2010","unstructured":"Zalila H, Elloumi H, Gaha N et al (2010) Acute psychosis under efavirenz in a HIV patient. Tunis Med 88(2):119\u2013121","journal-title":"Tunis Med"},{"key":"4157_CR26","unstructured":"Drug interactions charts. The University of Liverpool. http:\/\/www.hiv339druginteractions.org. Zugegriffen: 24.06.2014"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4157-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-014-4157-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4157-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T19:35:04Z","timestamp":1565811304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-014-4157-9"}},"subtitle":["Eine wichtige Differenzialdiagnose HIV-assoziierter Psychosen"],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1007\/s00115-014-4157-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]}}}